Liver Transplant Rejection Drugs Development Market

By Author: khansurry
Total Articles: 37
Comment this article

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection – Drugs In Development, 2022, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape.

Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability to regenerate or grow, unlike any other organ in the body. Liver transplant replaces an injured or diseased liver with a healthy one. An entire liver or just a section may be transplanted. Following a transplant, the immune system may consider the transplanted liver as foreign and may work against it. Patients may hence develop complications and ultimately reject the new organ. Therefore, immunosuppressive drugs are administered simultaneously. These immunosuppressive drugs prevent the body from either identifying or attacking the foreign organ via various immune responses thus blocking organ rejection and facilitating a successful transplant.

Click for Detail report:
https://bit.ly/3QqoRLf